1. Home
  2. VSME vs PMCB Comparison

VSME vs PMCB Comparison

Compare VSME & PMCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo VS Media Holdings Limited

VSME

VS Media Holdings Limited

HOLD

Current Price

$1.82

Market Cap

7.6M

Sector

N/A

ML Signal

HOLD

Logo PharmaCyte  Biotech Inc.

PMCB

PharmaCyte Biotech Inc.

HOLD

Current Price

$0.82

Market Cap

8.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VSME
PMCB
Founded
2013
1996
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.6M
8.3M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
VSME
PMCB
Price
$1.82
$0.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
484.6K
355.9K
Earning Date
04-14-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,483,152.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$0.63
52 Week High
$64.20
$1.90

Technical Indicators

Market Signals
Indicator
VSME
PMCB
Relative Strength Index (RSI) 63.68 44.95
Support Level $1.63 $0.76
Resistance Level $2.00 $1.05
Average True Range (ATR) 0.25 0.08
MACD -0.01 -0.01
Stochastic Oscillator 40.03 21.04

Price Performance

Historical Comparison
VSME
PMCB

About VSME VS Media Holdings Limited

VS Media Holdings Ltd manages a network of digital Creators who create and publish content to social media platforms such as YouTube, Facebook, Instagram, and TikTok. Its Creators include influencers, KOLs-Key Opinion Leaders, bloggers, and other content creators who cultivate fan bases on social media platforms. The company's business provides value to two business stakeholders: Creators and Brands. The Value to Creators, that empowers and supports Creators by providing them with production facilities, training, and funding to produce quality content and the Value to Brands, where the company bridges the divide between Brands and Creators by helping Brands reach their target audience effectively by advising on content and budget and recommending specific Creators.

About PMCB PharmaCyte Biotech Inc.

PharmaCyte Biotech Inc is a clinical-stage biotechnology company. The company is focused on developing and preparing to commercialize cellular therapies for cancer and diabetes based on a proprietary cellulose-based live cell encapsulation technology called Cell-in-a-Box. The Cell-in-a-Box technology is intended to be used as a platform upon which therapies for several types of cancer, including inoperable pancreatic cancer, and diabetes will be developed. The company is developing therapies for the pancreas and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of cancer.

Share on Social Networks: